ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Total liabilities

KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967)

Market cap
¥451.4B
P/E ratio
43x
Kobayashi Pharmaceutical makes healthcare products and consumer goods like deodorizers and oral care items, serving domestic and international markets through 40 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Dec 31, 202564,320+23.94%
Dec 31, 202451,896-17.17%
Dec 31, 202362,656+8.16%
Dec 31, 202257,927+1.71%
Dec 31, 202156,954+2.10%
Dec 31, 202055,783-8.16%
Dec 31, 201960,740-6.18%
Dec 31, 201864,740-0.43%
Dec 31, 201765,019+12.27%
Dec 31, 201657,914+23.29%
Mar 31, 201646,974+0.54%
Mar 31, 201546,720

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat